Life Sciences
The effort will be focused on using nocturnal scratch as an endpoint for atopic dermatitis.
The study will focus on Type 2 diabetes patients.
The study found only 46% of patients eligible for prophylactic low-dose aspirin due to high-risk factors for preeclampsia had gotten a provider recommendation by 16 weeks gestation.
The tool is aimed at helping people make informed decisions around vaccinations.
It has set up a new entity offering preventive healthcare solutions.
The technology can detect and analyse wound biomarkers within 15 minutes.
SonderMind said the purchase will help providers deliver personalized mental healthcare.
The deal is expected to close by the end of 2021.
HIMSS21
Naomi Fried, founder and CEO of PharmStars, discusses how her company mentors digital health startups and coaches pharma executives to prepare both parties for successful partnerships.
The partnership expands on the companies’ earlier collaboration announced in late 2019.